Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling

X Zhou, VE Torres - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
… a strategy that has already had success. The purpose of this manuscript is to review the role
of cAMP and PKA signaling … opportunities for targeting cAMP signaling in ADPKD have not …

Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling

CR Sussman, X Wang, FT Chebib, VE Torres - Cellular signalling, 2020 - Elsevier
… for many other diseases (35% of all approved drugs target G-… overview of general GPCR
signaling; the function of polycystin-1 (… and cAMP signaling; the cross-talk of calcium and cAMP

Targeting and therapeutic peptide-based strategies for polycystic kidney disease

J Wang, N Tripathy, EJ Chung - Advanced drug delivery reviews, 2020 - Elsevier
signaling pathways in PKD and renal receptors that can be potential targets of peptide-mediated
strategies… reduce pathways downstream of cAMP in a polycystic kidney disease rat (PCK…

[HTML][HTML] Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney disease

X Song, E Tsakiridis, GR Steinberg, Y Pei - Cellular Signalling, 2020 - Elsevier
cAMP]i to slow cyst growth and delay loss of kidney function, has been recently approved as
the first disease-modifier drug for treatment of ADPKD … in experimental studies of ADPKD [11,…

[HTML][HTML] Pre‐clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease

A Di Mise, X Wang, H Ye, L Pellegrini… - The FASEB …, 2021 - ncbi.nlm.nih.gov
cAMP level, and a reduction of mechanistic target of … treatment did. The rationale in this
approach is that a combination of drugs targeting simultaneously the complex signaling in ADPKD

New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease

TRM Barten, LHP Bernts, JPH Drenth… - … on Therapeutic Targets, 2020 - Taylor & Francis
… of polycystic kidney disease. While surgery has been the mainstay in … While drugs that
target cAMP, mTOR and bile acids were … strategies currently available for renal cystogenesis. …

Local cyclic adenosine monophosphate signalling cascades—Roles and targets in chronic kidney disease

A Sholokh, E Klussmann - Acta Physiologica, 2021 - Wiley Online Library
cAMP functions in cellular signalling processes that control … kidney functions and which
play a role in kidney diseases, … cAMP signalling compartments may lead to novel strategies

[HTML][HTML] Drug repurposing in autosomal dominant polycystic kidney disease

JX Zhou, VE Torres - Kidney international, 2023 - Elsevier
… Drug repurposing is a strategy for identifying new clinical … several ADPKD animal models
by inhibiting cAMP signaling and … targets of autosomal dominant polycystic kidney disease are …

Autosomal dominant polycystic kidney disease: from pathophysiology of cystogenesis to advances in the treatment

J Reiterová, V Tesař - International Journal of Molecular Sciences, 2022 - mdpi.com
cAMP as a driver of fluid secretion into the cysts in ADPKD … , inhibit cAMP-activated chloride
secretion by targeting CFTR in … Dietary strategies include daily caloric restriction, intermittent …

Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases

ETB Olesen, RA Fenton - Nature Reviews Nephrology, 2021 - nature.com
… models have suggested that cAMP signalling pathways are not … Another strategy for treating
ADPKD involves targeting the … of ADPKD, a process that is fuelled at least in part by cAMP-…